- 4-Week # shares sold: 12,500
- 12-Week # shares sold: 12,500
- 24-Week # shares sold: 75,000
Guess? (GES) reported an earnings beat and a smaller-than-expected drop in same-store sales for the fiscal 2017 second quarter.
Pfizer buys antibiotics business from AstraZeneca; Tesla unveils Model S version that can go 300 miles on a single charge; U.S. stock futures rise slightly.
Guess (GES) is expected to report fiscal 2017 second-quarter earnings and revenue after Wednesday's market close.